A phase I-II clinical trial to evaluate the safety, pharmacokinetics, and efficacy of high-dose intravenous ascorbic acid synergy with mEHT in Chinese patients with stage III-IV non-small cell lung cancer.

Junwen Ou,Xinyu Zhu,Yimin Lu,Changlin Zhao,Hongyu Zhang,Xinting Zhang,Tao Zhang,Clifford L.K. Pang

A phase I-II clinical trial to evaluate the safety, pharmacokinetics, and efficacy of high-dose intravenous ascorbic acid synergy with mEHT in Chinese patients with stage III-IV non-small cell lung cancer.

2017

Junwen Ou
Xinyu Zhu
Yimin Lu
Changlin Zhao
Hongyu Zhang
Xinting Zhang
Tao Zhang
Clifford L.K. Pang

e20078Background: Ascorbic acid (AA) infusion and modulated electrohyperthermia (mEHT) are widely used by integrative cancer practitioners for many years. However, there are no safety and pharmacok...

Keywords:

Clinical trial
Cancer research
Physical therapy
Lung cancer
Medicine
Pharmacokinetics
ascorbic acid
non small cell
phase i ii
Pharmacology
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations